BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 1107261 HOUSTON, TX

Position in TERN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

+$0 QoQ

Shares Held

12,000

-61.3% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	GLUE	Monte Rosa Therapeutics, Inc.	552,566	$13,372,097
2	INVA	Innoviva, Inc.	350,253	$7,954,245
3	PBYI	Puma Biotechnology, Inc.	791,616	$6,420,005
4	RIGL	Rigel Pharmaceuticals Inc	124,184	$4,858,078
5	EXEL	Exelixis, Inc.	66,100	$3,596,501
6	CRMD	CorMedix Inc.	434,132	$3,407,936
7	KROS	Keros Therapeutics, Inc.	265,017	$2,835,681
8	PTCT	Ptc Therapeutics, Inc.	22,000	$1,794,540

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	—	12,000	-61.3%	Shares	Sole	2026-05-15
2025-12-31	—	31,000	-67.4%	Shares	Sole	2026-02-17
2025-09-30	—	95,000	0.0%	Shares	Sole	2025-11-14
2025-06-30	—	95,000	+245.5%	Shares	Sole	2025-08-14
2023-09-30	—	27,500	-45.8%	Shares	Sole	2023-11-14
2023-06-30	—	50,700	0.0%	Shares	Sole	2023-08-14
2023-03-31	—	50,700	-45.3%	Shares	Sole	2023-05-15
2022-12-31	—	92,700	+33.4%	Shares	Sole	2023-02-14
2022-09-30	—	69,500	+52.7%	Shares	Sole	2022-11-14
2022-06-30	—	45,500	-27.4%	Shares	Sole	2022-08-15
2022-03-31	—	62,700	-34.3%	Shares	Sole	2022-05-16
2021-12-31	—	95,500	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.